BioNexus Gene Lab Corp Common stock

BGLCNASDAQ • USD
0.83 USD
↘ 0.03 (3.09%)AT CLOSE (03:59 PM EST)
0.80
↘ 0.03 (3.01%)
POST MARKET (AS OF 04:00 PM EST)
Post Market
AS OF 04:00 PM EST
0.80
↘ 0.03 (3.01%)
🔴Market: CLOSED

BioNexus Gene Lab Corp Common stock (BGLC) is currently trading at $0.83. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest BGLC is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 6, 2026.

Open?$0.86
High?$0.86
Low?$0.83
Prev. Close?$0.86
Volume?5.2K
Avg. Volume?9.4K
VWAP?$0.83
Rel. Volume?0.55x
Bid / Ask
Bid?$0.80 × 500
Ask?$0.85 × 1.2K
Spread?$0.05
Midpoint?$0.83
Valuation & Ratios
Market Cap?2.4M
Shares Out?2.9M
Float?1.8M
Float %?63.0%
P/E Ratio?N/A
P/B Ratio?0.31
EPS?-$0.88
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
Employees
1
Market Cap
2.5M
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2020-03-11
Address
UNIT A-28-7, TOWER A, MENARA UOA BANGSAR
KUALA LUMPUR, 59000
Phone: 1-307-241-6898
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
11
Momentum?
23
Short Sent.?
95
Piotroski F-Score?3/9Weak
Altman Z-Score?0.98Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.49%Low
Short Interest?9.1K
Days to Cover?1.0
Free Float1.8M
Avg Daily Volume13.3K
Settlement Date2026-10-15
Financial Health
Current Ratio?6.08Strong
Quick Ratio?5.28Strong
Cash Ratio?1.52Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.31CHEAP▾
P/S?
Peers
100
S&P
90
0.78CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.40CHEAP▾
Returns & Efficiency
ROE?
S&P
6
-33.1%WEAK▾
ROA?
S&P
3
-29.5%WEAK▾
Cash Flow & Enterprise
FCF?$-853600
Enterprise Value?$1.3M
Fundamentals ratios updated end of day